Cleared Traditional

K091218 - DBX DEMINERALIZED BONE MATRIX PUTTY

K091218 is the FDA 510(k) clearance for DBX DEMINERALIZED BONE MATRIX PUTTY by Musculoskeletal Transplant Foundation. It is a Class 2 Orthopedic device (product code MQV) cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K091218 · Musculoskeletal Transplant Foundation · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2009
Decision
154d
Days
Class 2
Risk

K091218 is an FDA 510(k) clearance for the DBX DEMINERALIZED BONE MATRIX PUTTY. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Musculoskeletal Transplant Foundation (Edison, US). The FDA issued a Cleared decision on September 28, 2009 after a review of 154 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Musculoskeletal Transplant Foundation devices

Submission Details

510(k) Number K091218 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2009
Decision Date September 28, 2009
Days to Decision 154 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 122d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 231
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K091218.
NANOSS BONE VOID FILLER
K100361 · Pioneer Surgical Technology · Apr 2010
INTEGRA MOZAIK AND OS MOLDABLE MORSELS
K091302 · Integra LifeSciences Corporation · Dec 2009
PIONEER SURGICAL NANOSS BVF-E
K091031 · Pioneer Surgical Technology · Nov 2009
WMT COMPOSITE DBM
K083270 · Wrightmedicaltechnologyinc · Aug 2009
E-MATRIX GRAFT BONE EXTENDER
K083449 · Pioneer Surgical Technology · Jun 2009
MASTERGRAFT STRIP
K082166 · Medtronic Sofamor Danek · Jun 2009